Long-term outcome study supports use of Afirma genomic test for thyroid nodule patients

Veracyte, Inc., a molecular diagnostics company pioneering the field of molecular cytology, today announced the publication of new long-term outcome data supporting the use of the Afirma Gene…
Source: Recent MedGen News